| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 44.663 | 12.928 | 2.248 | 0 | 0 | 0 | - | - | - | - |
| Total Income - EUR | 44.670 | 12.929 | 2.248 | 0 | 0 | 0 | - | - | - | - |
| Total Expenses - EUR | 41.603 | 34.179 | 24.191 | 1.302 | 1.539 | 15.607 | - | - | - | - |
| Gross Profit/Loss - EUR | 3.067 | -21.250 | -21.943 | -1.302 | -1.539 | -15.607 | - | - | - | - |
| Net Profit/Loss - EUR | 1.724 | -21.854 | -22.010 | -1.302 | -1.539 | -15.607 | - | - | - | - |
| Employees | 1 | 1 | 0 | 0 | 0 | 3 | - | - | - | - |
Check the financial reports for the company - Asclepimed Trading & Services S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 12.555 | 11.121 | 6.011 | 4.640 | 3.247 | 3.186 | - | - | - | - |
| Current Assets | 49.783 | 45.132 | 49.153 | 48.247 | 47.163 | 47.241 | - | - | - | - |
| Inventories | 4.583 | 22.267 | 21.890 | 21.489 | 20.922 | 20.525 | - | - | - | - |
| Receivables | 41.158 | 24.371 | 27.245 | 26.745 | 26.227 | 25.730 | - | - | - | - |
| Cash | 4.042 | -1.507 | 18 | 14 | 13 | 985 | - | - | - | - |
| Shareholders Funds | -44.644 | -66.043 | -86.936 | -86.642 | -86.504 | -100.471 | - | - | - | - |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | - | - | - | - |
| Debts | 107.073 | 122.386 | 142.189 | 139.617 | 136.913 | 150.897 | - | - | - | - |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | - | - | - | - |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4646 - 4646" | |||||||||
| CAEN Financial Year |
4646
|
|||||||||
Comments - Asclepimed Trading & Services S.r.l.